CITY THERAPEUTICS, INC. (CTY)
City Therapeutics, Inc. is a biotechnology company specializing in next-generation RNA interference (RNAi) therapeutics. The company is based in Cambridge, MA. The company engineers potent, specific, and durable RNAi trigger molecules combined with precision targeting ligands to deliver siRNAs beyond the liver to tissues such as ocular and central nervous system targets. Its R&D pipeline includes programs addressing thromboembolic diseases (targeting Factor XI), Stargardt disease (targeting RBP4), and other hepatic, ocular, and CNS conditions. Lead candidates include CITY-FXI, designed to prevent blood clots with reduced bleeding risk, and CITY-RBP4, aimed at slowing or halting vision loss in Stargardt disease. The company was founded by Ari Nowacek, John M. Maraganore. Andrew C. Orth has been the CEO of the company since 2025.
Sector: Pharmaceutical Preparations
Industry: Biotechnology
City Therapeutics Inc.
NASDAQ:CTYHealthcare · Biotechnology
+0.00%$20.77
AH Close$20.77+0.00%vs close
AH Close$20.77+0.00%vs close
Mkt Cap$1.05B
Float45.91M
O/S50.33M
Inst Own-
Dilution
Delisting Issues Timeline
Financials Summary
Revenue$8.16B
Net Income$1.83B
Total Assets$21B
Free Cash Flow$2.28B
Debt & Equity
Debt 37%
Equity 63%
Total Debt$5.95B
Total Equity$10.12B
Shares Outstanding
Short Interest
Split History
No splits on record
Nothing in CTY's public trading history: no forward or reverse split has affected the share count.
Balance Sheet Details
Assets$21B
Liabilities$10.88B
Accounts Receivable$514M
Accounts Payable$403M
Inventory$0
PP&E (Net)$8.17B
Goodwill$9.36B
Intangible Assets$468M
Income Statement
| Period | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 | FY 2010 | FY 2009 | FY 2008 | FY 2007 | FY 2006 | FY 2005 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 | 2008-12-31 | 2007-12-31 | 2006-12-31 | 2005-12-31 |
| Revenue | $8.16B | $8.49B | $8.55B | $8.91B | $8.96B | $8.84B | $8.75B | $8.85B | $6.63B | $9.27B | $9.73B | $10.39B | $9.88B | $9.87B | $10.05B |
| YoY Growth | -4.0% | -0.7% | -4.0% | -0.6% | 1.4% | 1.0% | -1.1% | 33.4% | -28.4% | -4.7% | -6.3% | 5.2% | 0.1% | -1.8% | - |
| Cost of Revenue | $2.44B | $2.77B | $2.88B | $2.93B | $2.87B | $2.88B | $2.79B | $2.87B | $1.83B | $1.66B | $1.5B | $1.69B | $2.14B | $2.32B | $2.38B |
| Gross Profit | $5.72B | $5.73B | $5.67B | $5.98B | $6.09B | $5.96B | $5.96B | $5.98B | $4.8B | $7.62B | $8.23B | $8.7B | $7.74B | $7.55B | $7.67B |
| Gross Margin | 70.1% | 67.4% | 66.3% | 67.1% | 68.0% | 67.4% | 68.1% | 67.6% | 72.4% | 82.1% | 84.5% | 83.8% | 78.4% | 76.5% | 76.3% |
| Research and Development | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Selling, General, and Administrative | $659M | $799M | $925M | $1.02B | $1.01B | $1.09B | $1.06B | $1.17B | $1.5B | $1.61B | $1.85B | $1.74B | $1.64B | $1.73B | $1.75B |
| Other | $0 | $5.03B | $5.31B | $5.57B | $5.69B | $5.64B | $5.61B | $5.78B | $3.94B | $5.18B | $5.32B | $5.79B | $5.24B | $5.74B | $6.14B |
| Total Operating Expenses | $659M | $5.83B | $6.24B | $6.59B | $6.7B | $6.73B | $6.67B | $6.94B | $5.44B | $6.79B | $7.17B | $7.53B | $6.88B | $7.47B | $7.89B |
| Operating Income (EBIT) | $2.88B | $2.66B | $2.31B | $2.32B | $2.26B | $2.11B | $2.08B | $1.91B | $1.2B | $2.48B | $2.56B | $2.27B | $2.38B | $1.2B | $989M |
| Operating Margin | 35.4% | 31.3% | 27.1% | 26.1% | 25.2% | 23.9% | 23.7% | 21.5% | 18.1% | 26.8% | 26.3% | 21.8% | 24.1% | 12.2% | 9.8% |
| Interest Expense | $0 | $448M | $465M | $478M | $473M | $464M | $450M | $443M | $0 | -$615M | -$632M | -$589M | -$610M | -$616M | -$607M |
| Interest Income | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Income (Expense) | -$416M | -$501M | -$522M | -$559M | -$527M | -$503M | -$512M | -$514M | -$307M | -$610M | -$641M | $0 | $0 | $648M | $541M |
| Income Before Tax (EBT) | $2.47B | $2.16B | $1.79B | $1.76B | $1.73B | $1.61B | $1.57B | $1.39B | $892M | $1.87B | $1.92B | $2.27B | $2.38B | $1.85B | $1.53B |
| Income Tax Expense | $641M | $494M | $134M | $678M | $659M | $639M | $602M | $542M | $349M | $791M | $724M | $829M | $885M | $648M | -$541M |
| Net Income | $1.83B | $1.67B | $1.66B | $1.08B | $1.07B | $970M | $964M | $849M | $543M | $1.08B | $1.2B | $1.44B | $1.49B | $1.2B | $977M |
| Net Income Margin | 22.4% | 19.6% | 19.4% | 12.2% | 12.0% | 11.0% | 11.0% | 9.6% | 8.2% | 11.7% | 12.3% | 13.8% | 15.1% | 12.2% | 9.7% |
| Supplementary Data | |||||||||||||||
| EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Weighted Average OS | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBITDA | $3.83B | $4.04B | $3.84B | $3.92B | $4.04B | $4.04B | $4.09B | $4.06B | $2.76B | $3.13B | $3.27B | $3.75B | $3.85B | $2.3B | $2.49B |
| EBITDA Margin | 47.0% | 47.6% | 44.9% | 44.0% | 45.1% | 45.7% | 46.7% | 45.9% | 41.6% | 33.8% | 33.6% | 36.1% | 39.0% | 23.3% | 24.8% |
Balance Sheet
| Period | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 | FY 2010 | FY 2009 | FY 2008 | FY 2007 | FY 2006 | FY 2005 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 | 2008-12-31 | 2007-12-31 | 2006-12-31 | 2005-12-31 |
| Assets | |||||||||||||||
| Current Assets | |||||||||||||||
| Cash and Cash Equivalents | $2M | $5M | $1M | $5M | $3M | $6M | $14M | $8M | $3M | $5M | $17M | $41M | $24M | $274M | $24M |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $20M | $42M | $8M |
| Cash and Short-Term Investments | $2M | $5M | $1M | $5M | $3M | $6M | $14M | $8M | $3M | $5M | $17M | $41M | $44M | $316M | $32M |
| Accounts Receivable | $514M | $546M | $646M | $700M | $688M | $740M | $738M | $709M | $712M | -$22M | $48M | $3M | -$37M | $1.03B | -$27M |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Current Assets | $1.97B | $1.29B | $1.12B | $1B | $911M | $1.1B | $999M | $856M | $464M | $1.48B | $2.21B | $1.67B | $1.73B | $504M | $1.63B |
| Total Current Assets | $2.49B | $1.85B | $1.77B | $1.71B | $1.6B | $1.85B | $1.75B | $1.57B | $1.18B | $1.46B | $2.27B | $1.71B | $1.74B | $1.85B | $1.63B |
| Long-Term Assets | |||||||||||||||
| Property, Plant & Equipment Net | $8.17B | $8.08B | $7.92B | $7.64B | $7.37B | $7.2B | $7.21B | $7.23B | $7.54B | -$1.24B | -$1.11B | -$1.4B | -$1.04B | $12.99B | -$1.23B |
| Goodwill | $9.36B | $9.36B | $9.36B | $9.35B | $9.35B | $9.35B | $9.35B | $9.37B | $9.45B | $0 | $0 | $0 | $0 | $0 | $0 |
| Intangible Assets | $468M | $893M | $1.36B | $1.88B | $2.44B | $3.04B | $1.01B | $4.38B | $5.1B | $0 | $0 | $0 | $0 | $0 | -$1.23B |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Deferred Tax Assets | $0 | $0 | $0 | $0 | $0 | $163M | $161M | $149M | $168M | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Assets | $515M | $407M | $454M | $567M | $705M | $854M | -$3.47B | -$5.99B | -$6.05B | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Long-Term Assets | $18.51B | $18.74B | $19.1B | $19.44B | $19.87B | $20.61B | $14.26B | $15.14B | $16.21B | -$1.24B | -$1.11B | -$1.4B | -$1.04B | $12.99B | -$2.46B |
| Other Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $21B | $20.58B | $20.87B | $21.15B | $21.47B | $22.46B | $16.01B | $16.71B | $17.39B | $221M | $1.17B | $307M | $700M | $14.85B | -$834M |
| Liabilities | |||||||||||||||
| Current Liabilities | |||||||||||||||
| Accounts Payable | $403M | $441M | $317M | $398M | $369M | $464M | $440M | $456M | $654M | -$3M | $28M | -$112M | -$29M | $392M | -$31M |
| Short-Term Debt | $1.1B | $11M | $17M | $514M | $242M | $117M | $637M | $804M | $64M | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Income Tax Payable | $94M | $140M | $174M | $175M | $189M | $197M | $206M | $215M | $221M | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Unearned Revenue | $201M | $212M | $128M | $131M | $137M | $327M | $320M | $301M | $273M | $241M | -$137M | $215M | -$227M | $180M | -$302M |
| Other Current Liabilities | $1.7B | $1.61B | $1.73B | $1.75B | $1.67B | $1.35B | $1.3B | $1.27B | $1.11B | $2.94B | $2.85B | $2.45B | $2.85B | $1.93B | $2.7B |
| Total Current Liabilities | $3.41B | $2.27B | $2.2B | $2.8B | $2.42B | $2.26B | $2.7B | $2.83B | $2.1B | $3.18B | $2.75B | $2.55B | $2.6B | $2.5B | $2.37B |
| Long-Term Liabilities | |||||||||||||||
| Long-Term Debt | $4.85B | $5.95B | $7.26B | $6.75B | $7B | $7.26B | $6.92B | $6.82B | $8.26B | -$3M | $28M | -$112M | -$29M | $782M | -$1.16B |
| Long-Term Unearned Revenue | $108M | $91M | $128M | $131M | $137M | $153M | $161M | $130M | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Deferred Tax Liabilities | $1.2B | $1.1B | $1B | $1.77B | $1.9B | $2.25B | $2.47B | $2.63B | $2.86B | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Liabilities | $515M | $547M | $82M | $66M | $60M | $80M | $0 | $0 | $0 | $26M | $90M | -$116M | -$49M | $220M | $47M |
| Total Long-Term Liabilities | $6.67B | $7.68B | $8.47B | $8.72B | $9.09B | $9.74B | $9.55B | $9.58B | $11.12B | $23M | $118M | -$228M | -$78M | $1B | -$1.11B |
| Other Liabilities | $806M | $759M | $861M | $944M | $1.05B | $1.27B | $1.35B | $1.56B | $1.83B | $11.32B | $11.86B | $12.33B | $11.9B | $11.24B | $13.98B |
| Total Liabilities | $10.88B | $10.71B | $11.53B | $12.46B | $12.56B | $13.27B | $13.61B | $13.97B | $15.04B | $14.52B | $14.73B | $14.66B | $14.42B | $14.74B | $15.23B |
| Stockholders' Equity | |||||||||||||||
| Preferred Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Common Stock | $10.05B | $10.05B | $10.05B | $10.05B | $10.05B | $10.05B | $10.05B | $10.05B | $9.97B | $11.43B | $11.35B | $11.33B | $10.51B | $10.35B | $10.16B |
| Retained Earnings | $67M | -$182M | -$713M | -$1.36B | -$1.14B | -$867M | -$437M | -$76M | -$85M | $0 | $0 | $0 | $0 | $0 | $0 |
| Comprehensive Income & Other | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Stockholders' Equity | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -$12.26B | -$11.03B | -$10.54B | -$9.54B | -$8.62B | -$7.82B |
| Total Equity | $10.12B | $9.87B | $9.34B | $8.69B | $8.91B | $9.18B | $9.61B | $9.97B | $9.89B | -$831M | $312M | $786M | $977M | $1.73B | $2.34B |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities and Equity | $21B | $20.58B | $20.87B | $21.15B | $21.47B | $22.46B | $23.22B | $23.95B | $24.93B | $13.69B | $15.04B | $15.44B | $15.4B | $16.47B | $17.57B |
| Supplementary Data | |||||||||||||||
| Total Debt | $5.95B | $5.96B | $7.28B | $7.26B | $7.24B | $7.38B | $7.56B | $7.63B | $8.32B | $7.21B | $7.96B | $7.65B | $7.63B | $7.61B | $7.73B |
| Net Debt | $5.95B | $5.95B | $7.28B | $7.26B | $7.24B | $7.37B | $7.54B | $7.62B | $8.32B | $7.21B | $7.94B | $7.61B | $7.61B | $7.34B | $7.71B |
Cash Flow Statement
| Period | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 | FY 2010 | FY 2009 | FY 2008 | FY 2007 | FY 2006 | FY 2005 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 | 2008-12-31 | 2007-12-31 | 2006-12-31 | 2005-12-31 |
| Operating Activities | |||||||||||||||
| Net Income | $1.83B | $1.67B | $1.66B | $1.08B | $1.07B | $970M | $964M | $849M | $543M | $1.08B | $1.2B | $1.44B | $1.49B | $1.2B | $977M |
| Depreciation & Amortization | $1.36B | $1.44B | $1.58B | $1.68B | $1.84B | $1.97B | $2.08B | $2.23B | $1.87B | $1.87B | $1.98B | $2.07B | $2.09B | $2.36B | $2.66B |
| Deferred Income Tax | -$100M | -$48M | $773M | $123M | $189M | $228M | $152M | $201M | $150M | $241M | -$137M | $215M | -$227M | -$288M | -$302M |
| Stock-Based Compensation | $26M | $24M | $27M | $22M | $21M | $21M | $17M | $18.3M | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Changes in Working Capital: | |||||||||||||||
| Accounts Receivable | -$19M | $40M | -$20M | -$92M | -$26M | -$66M | -$94M | -$76M | -$71M | -$22M | $48M | $3M | -$37M | -$81M | -$27M |
| Inventory | $495M | $318M | $1.15B | $907M | $520M | $1.02B | $1.35B | $1.05B | $1.83B | $499M | $765M | $967M | $713M | $798M | $1.07B |
| Accounts Payable | -$50M | $69M | -$44M | $5M | -$79M | -$9M | -$1M | -$58M | -$47M | -$3M | $28M | -$112M | -$29M | $20M | -$31M |
| Other Working Capital | -$923M | -$426M | -$427M | -$1.09B | -$820M | -$415M | -$949M | -$1.26B | -$918M | -$1.72B | -$474M | -$841M | -$858M | -$647M | -$737M |
| Total Working Capital Change | -$497M | $1M | $663M | -$270M | -$405M | $534M | $310M | -$341M | $798M | -$1.24B | $367M | $17M | -$211M | $90M | $280M |
| Other Non-Cash Items | $712M | $712M | -$2.27B | $13M | -$127M | -$918M | -$806M | -$178.3M | -$1.16B | $1.28B | -$236M | -$264M | $119M | -$232M | -$198M |
| Net Cash from Operating | $3.33B | $3.79B | $2.44B | $2.65B | $2.59B | $2.8B | $2.71B | $2.77B | $2.2B | $3.23B | $3.17B | $3.48B | $3.26B | $3.13B | $3.42B |
| Investing Activities | |||||||||||||||
| Capital Expenditures | -$1.05B | -$1.04B | -$1.33B | -$1.26B | -$1.25B | -$1.17B | -$1.26B | -$1.27B | -$1.04B | -$1.24B | -$1.11B | -$1.4B | -$1.04B | -$1.19B | -$1.23B |
| Acquisitions | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Purchases of Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $16M | $0 | $210M |
| Sales of Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Investing Activities | -$668M | -$113M | -$108M | -$75M | $27M | -$86M | -$117M | -$262M | $1.04B | -$16M | $6M | $2M | $2M | $131M | $9M |
| Net Cash from Investing | -$1.72B | -$1.15B | -$1.44B | -$1.33B | -$1.22B | -$1.25B | -$1.38B | -$1.53B | $3M | -$1.26B | -$1.1B | -$1.4B | -$1.02B | -$1.06B | -$1.01B |
| Financing Activities | |||||||||||||||
| Debt Repaid | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Common Stock Issuance | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Common Stock Repurchases | -$2M | -$5M | -$1M | -$5M | -$3M | -$6M | -$14M | -$8M | -$3M | $0 | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | -$1.6B | -$1.27B | -$1B | -$1.3B | -$1.35B | -$1.4B | -$1.32B | -$1.15B | -$900M | -$2.26B | -$2B | -$2B | -$2.4B | -$1.93B | -$2.54B |
| Other Financing Activities | -$12M | -$1.36B | -$3M | -$16M | -$24M | -$158M | -$1M | -$91M | -$308M | -$541M | $714M | -$136M | $168M | -$36M | -$49M |
| Net Cash from Financing | -$1.61B | -$2.63B | -$1B | -$1.32B | -$1.37B | -$1.56B | -$1.33B | -$1.24B | -$1.21B | -$2.8B | -$1.29B | -$2.14B | -$2.23B | -$1.96B | -$2.58B |
| Forex Effect | -$2M | -$2M | $0 | $0 | $0 | $0 | $0 | $0 | -$1.19B | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Change in Cash | -$5M | $2M | -$4M | $2M | -$3M | -$8M | $6M | $5M | -$198M | -$822M | $781M | -$59M | $9M | $114M | -$182M |
| Supplementary Data | |||||||||||||||
| Operating Cash Flow | $3.33B | $3.79B | $2.44B | $2.65B | $2.59B | $2.8B | $2.71B | $2.77B | $2.2B | $3.23B | $3.17B | $3.48B | $3.26B | $3.13B | $3.42B |
| Capital Expenditure | -$1.05B | -$1.04B | -$1.33B | -$1.26B | -$1.25B | -$1.17B | -$1.26B | -$1.27B | -$1.04B | -$1.24B | -$1.11B | -$1.4B | -$1.04B | -$1.19B | -$1.23B |
| Free Cash Flow | $2.28B | $2.75B | $1.11B | $1.39B | $1.34B | $1.64B | $1.45B | $1.51B | $1.17B | $2B | $2.06B | $2.08B | $2.22B | $1.95B | $2.18B |
| Cash at Beginning | $7M | $3M | $5M | $3M | $6M | $14M | $8M | $3M | $201M | $0 | $0 | $0 | $0 | $0 | $0 |
| Cash at End | $2M | $5M | $1M | $5M | $3M | $6M | $14M | $8M | $3M | -$822M | $781M | -$59M | $9M | $114M | -$182M |